An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth

BACKGROUND: Recent reports of the remarkable therapeutic efficacy of 225Ac-labeled PSMA-617 for therapy of metastatic castration-resistant prostate cancer have under-lined the clinical potential of targeted alpha therapy. OBJECTIVE AND CONCLUSION: This review describes methods for the production of...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgenstern, Alfred, Apostolidis, Christos, Kratochwil, Clemens, Sathekge, Mike, Krolicki, Leszek, Bruchertseifer, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237921/
https://www.ncbi.nlm.nih.gov/pubmed/29732998
http://dx.doi.org/10.2174/1874471011666180502104524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237921/
https://www.ncbi.nlm.nih.gov/pubmed/29732998
http://dx.doi.org/10.2174/1874471011666180502104524

Ejemplares similares